<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03604549</url>
  </required_header>
  <id_info>
    <org_study_id>00008466</org_study_id>
    <nct_id>NCT03604549</nct_id>
  </id_info>
  <brief_title>Sonographic Hysterosalpingography: Oil vs Water Based Media (SHOW Trial)</brief_title>
  <official_title>Therapeutic Effect of Sonographic Hysterosalpingography: Oil vs Water Based Media</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Milton S. Hershey Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Guerbet</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Milton S. Hershey Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Performing fluoroscopic HSG with oil based contrast medium has been shown to increase&#xD;
      pregnancy rates in a subfertile population. This is a pilot study to test the efficacy of as&#xD;
      well as the tolerability and safety of using lipid based oil medium for sonographic based&#xD;
      hysterosalpingography (Sono HSG) compared to water based contrast (i.e. normal saline) for&#xD;
      women seeking fertility. The double blind study will randomize 56 women at the time of Sono&#xD;
      HSG in a 1:1 ratio to receive through the SHG catheter either up to 10 cc of Lipiodol UF® or&#xD;
      normal saline. The investigators will collect subjective pain experience and follow the&#xD;
      subjects for 6 months after the test for pregnancy and collect all adverse events during and&#xD;
      after the procedure.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 11, 2019</start_date>
  <completion_date type="Actual">August 25, 2021</completion_date>
  <primary_completion_date type="Actual">May 31, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ongoing pregnancy rate</measure>
    <time_frame>within 6 months of Sono HSG procedure</time_frame>
    <description>8 week viable intrauterine pregnancy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedural related pain assessed by visual analog scale</measure>
    <time_frame>at time of Sono HSG procedure</time_frame>
    <description>scale ranges from 1-10 with a higher score indicating more pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Live birth rate</measure>
    <time_frame>up to 15 months after Sono HSG procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Women in this arm will receive a flush with saline after normal saline Sono HSG.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lipiodol UF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women in this arm will receive a flush with Lipiodol UF after normal saline Sono HSG.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lipiodol UF</intervention_name>
    <description>Up to 10cc of Lipiodol Ultra Fluid will be infused via intrauterine catheter</description>
    <arm_group_label>Lipiodol UF</arm_group_label>
    <other_name>Lipiodol Ultra Fluid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Up to 10cc of saline will be infused via intrauterine catheter</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Eligible for Sono HSG for fertility testing&#xD;
&#xD;
          -  In good general health&#xD;
&#xD;
          -  Willing and capable of complying with the study procedures&#xD;
&#xD;
          -  At least one patent tube and no endometrial pathology on Sono HSG&#xD;
&#xD;
          -  Ready to undergo infertility treatment immediately after the test&#xD;
&#xD;
          -  Not planning on IVF therapy in the next 6 mos&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known tubal or endometrial (polyp, submucous fibroid, etc.) pathology&#xD;
&#xD;
          -  At high risk for tubal disease due to history of Pelvic Inflammatory Disease&#xD;
&#xD;
          -  Known hypersensitivity to Lipiodol UF®or known allergy to iodine containing contrast&#xD;
             media or shellfish&#xD;
&#xD;
          -  Endometrial pathology on Sono HSG requiring further evaluation (as per the performing&#xD;
             physician)&#xD;
&#xD;
          -  Bilateral tubal occlusion on Sono HSG&#xD;
&#xD;
          -  Unable to tolerate potential pain associated with the study.&#xD;
&#xD;
          -  Requiring IVF due to severe male factor, known pelvic adhesions, etc.&#xD;
&#xD;
          -  Couples with decreased male factor fertility rate (i.e., low sperm count or motility,&#xD;
             i.e. less than 5 million/mL concentration on semen analysis&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Legro, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Penn State University and Milton S. Hershey Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Penn State Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 10, 2018</study_first_submitted>
  <study_first_submitted_qc>July 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 27, 2018</study_first_posted>
  <last_update_submitted>August 26, 2021</last_update_submitted>
  <last_update_submitted_qc>August 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Milton S. Hershey Medical Center</investigator_affiliation>
    <investigator_full_name>Richard S. Legro, M.D.</investigator_full_name>
    <investigator_title>Interim Chair and Vice Chair of Research, Department of Obstetrics and Gynecology, Professor of Obstetrics and Gynecology and Public Health Sciences</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethiodized Oil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

